JSPR - Jasper Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

JSPR is currently covered by 8 analysts with an average price target of $46.04. This is a potential upside of $42.07 (1059.7%) from yesterday's end of day stock price of $3.97.

Jasper Therapeutics's activity chart (see below) currently has 18 price targets and 42 ratings on display. The stock rating distribution of JSPR is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 1.79% with an average time for these price targets to be met of 56.63 days.

Highest price target for JSPR is $40, Lowest price target is $40, average price target is $57.13.

Most recent stock forecast was given by EMILY BODNAR from HC WAINWRIGHT on 11-Mar-2025. First documented stock forecast 14-Oct-2021.

Currently out of the existing stock ratings of JSPR, 27 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$40

$35.84 (861.54%)

1 months 6 days ago
(11-Mar-2025)

0/8 (0%)

$34.65 (647.66%)

Buy

$70

3 months 7 days ago
(10-Jan-2025)

0/4 (0%)

$49.13 (235.41%)

Buy

$68

3 months 9 days ago
(08-Jan-2025)

0/3 (0%)

$45.88 (207.41%)

Buy

$90

3 months 9 days ago
(08-Jan-2025)

0/1 (0%)

$68.88 (326.14%)

Buy

$80

$75.84 (1823.08%)

1 years 1 months 10 days ago
(07-Mar-2024)

0/2 (0%)

$53.3 (199.63%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is JSPR (Jasper Therapeutics) average time for price targets to be met?

On average it took 56.63 days on average for the stock forecasts to be realized with a an average price target met ratio 1.79

Which analyst has the current highest performing score on JSPR (Jasper Therapeutics) with a proven track record?

JUDAH FROMMER

Which analyst has the current lower performing score on JSPR (Jasper Therapeutics) with a proven track record?

JUSTIN ZELIN

Which analyst has the most public recommendations on JSPR (Jasper Therapeutics)?

Judah Frommer works at MORGAN STANLEY and has 7 price targets and 5 ratings on JSPR

Which analyst is the currently most bullish on JSPR (Jasper Therapeutics)?

Jay Olson with highest potential upside - $75.84

Which analyst is the currently most reserved on JSPR (Jasper Therapeutics)?

Silvan Tuerkcan with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?